Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

Authors

David M. Nathan
Peter H. Bennett
Jill P. Crandall
Sharon L. Edelstein, George Washington University
Ronald B. Goldberg
Steven E. Kahn
William C. Knowler
Kieren J. Mather
Sunder Mudaliar
Trevor J. Orchard
Marinella Temprosa, George Washington University
Neil H. White

Document Type

Journal Article

Publication Date

8-1-2019

Journal

Diabetologia

Volume

62

Issue

8

Inclusive Pages

1319-1328

DOI

10.1007/s00125-019-4928-8

Keywords

Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetes Complications; Diabetes Mellitus, Type 2; Follow-Up Studies; Glucose Intolerance; Humans; Hypoglycemic Agents; Life Style; Metformin; Microcirculation; Preventive Medicine; Ramipril; Risk Factors; Rosiglitazone; Treatment Outcome

Comments

Epub 2019 Jul 4

Recommended Citation

Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., Orchard, T. J., Temprosa, M., & White, N. H. (2019). Does diabetes prevention translate into reduced long-term vascular complications of diabetes?. Diabetologia, 62 (8). http://dx.doi.org/10.1007/s00125-019-4928-8

Peer Reviewed

1